Assessing spatial cognition using virtual reality
Spatial Cognition Assessment in Virtual Reality
This study is testing if virtual reality can help better understand and treat people with spatial neglect after a stroke.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Université Paris Cité Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT05723146 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate unilateral spatial neglect (USN), a common condition following a stroke, using immersive virtual reality (VR) technology. By creating a realistic environment for assessment, the researchers hope to overcome traditional limitations in diagnosing and rehabilitating USN. Participants will undergo a multisensory evaluation designed to accurately diagnose their condition. The innovative use of VR may provide a more effective means of understanding and addressing spatial neglect.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have experienced a unilateral right stroke.
Not a fit: Patients with epilepsy, major sensory or motor deficits, or severe cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved diagnostic methods and rehabilitation strategies for patients with spatial neglect.
How similar studies have performed: While the use of virtual reality for cognitive assessment is emerging, this specific application for spatial neglect is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * unilateral right stroke Exclusion Criteria: * epilepsy / migraine * craniotomy * major sensory/motor deficit * severe cognitive impairment
Where this trial is running
Paris
- Université Paris Cité — Paris, France (Recruiting)
Study contacts
- Study coordinator: Alma Guilbert, PhD
- Email: alma.guilbert@u-paris.fr
- Phone: +33176533178
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.